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To understand further the molecular events underlying the process of Varicella-zoster virus (VZV) latency in human
ganglionic tissues, in situ hybridisation (ISH) for VZV RNA and DNA, and PCR in situ amplification for VZV DNA were used
in human dorsal root ganglia from 12 individuals (3 normal and 9 who had died with AIDS). The results showed that (a) two
separate regions of the VZV genome, represented by genes 4 and 40, were detected in neurons in two normal and three AIDS
ganglia, (b) evidence of transcription of VZV genes 4, 21, 29, and 63 was found in normal and AIDS cases, and (c) VZV DNA
and RNA for the same gene (gene 29) was detected in neurons in serial tissue sections in three cases. Thus more than one
region of the VZV genome is present in neurons during VZV ganglionic latency, and the presence of both a VZV gene and its
corresponding RNA transcript can be shown to occur in the same localised region of DRG tissue. © 1999 Academic PressKey Words: varicella-zoster virus; neuron; dorsal root ganglion.
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iINTRODUCTION
The human herpesvirus Varicella-zoster virus (VZV)
auses varicella (chickenpox) as a primary infection,
sually in children, following which it establishes a latent
nfection in human trigeminal and dorsal root ganglia
DRG) (Kennedy 1987; Johnson 1998). Following a variety
f possible triggering factors, or spontaneously, VZV may
hen reactivate to cause herpes zoster (shingles), which
ay be followed by postherpetic neuralgia. The latter is
n important cause of human morbidity, and both types
f VZV infection may lead to a variety of serious neuro-
ogical complications, particularly in immunocompro-
ised individuals, including those with Human Immuno-
eficiency Virus (HIV) infection (Kennedy 1987). An im-
ortant pathogenetic question is the cell specificity of
atent VZV because knowledge of this will help the un-
erstanding of how viral reactivation and the various
omplications occur. The cellular location of latent VZV in
uman ganglia had for several years remained a contro-
ersial issue (Hyman et al., 1983; Gilden et al., 1987;
roen et al., 1988; Meier et al., 1993), but it has recently
een established that the neuron is the predominant site
f latent viral infection (Kennedy et al., 1998), although
here is not currently a consensus as to the exact fre-
uency of neuronal or nonneuronal satellite cells, which
upport latent VZV (Lungu et al., 1995; Kennedy et al.,
998). We have consistently detected latent VZV in only a
mall percentage of satellite cells (Kennedy et al., 1998).
Three of the important questions that remain to be
1 To whom reprint requests should be addressed. Fax: 44 141 201
g993. E-mail: P.G.Kennedy@clinmed.gla.ac.uk.
451larified and confirmed following previous studies are (a)
hether the predominant neuronal localisation of latent
ZV in trigeminal ganglia also exists in the DRG—the
ther main site of human VZV latency, (b) whether sep-
rate regions of the VZV genome can be detected in
eurons in areas of the same human ganglion indicating
he presence of the entire genome rather than fragments,
nd (c) whether it is possible to detect the presence of
oth a particular VZV gene and evidence of its transcrip-
ion in the same ganglionic region and/or cell. We there-
ore used previously employed molecular techniques to
ddress these issues.
RESULTS AND DISCUSSION
Using the PCR in situ technique, DNA for more than
ne VZV gene was detected in the same areas in neu-
ons in serial sections of several of the DRG tissues.
hus two separate regions of the VZV genome, repre-
ented by genes 4 and 40, were detected in five of the
ases (2 of the 3 normal and 3 of the AIDS cases) (Fig 1).
pproximately 2–5% of the neurons in the DRG sections
ere positive for viral DNA, and only occasional nonneu-
onal satellite cells were labeled. The relatively small
ample size did not allow for statistical analysis. As
xpected, the results using ISH showed a very similar
attern of VZV DNA labelling. A limited screen for VZV
NA using ISH with probes to VZV genes 4, 21, 29, and 63
howed that all of these genes were transcribed in vary-
ng numbers of cases. Thus RNA for gene 21 was de-
ected in one case, for gene 29 in nine cases, for gene 63
n eight cases, and for gene 4 in two cases. Furthermore
n three cases, both VZV DNA and RNA for the same
ene (gene 29) were detected in neurons in serial tissue
0042-6822/99 $30.00
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452 KENNEDY, GRINFELD, AND GOWections (Fig. 1). It was not possible to determine un-
quivocally whether the exact same neuron containing
ZV DNA also contained RNA of the same gene, but our
ata suggest that this is probably the case, at least in
ome instances. VZV DNA or RNA was always detected
n the neuronal nucleus, and not the cytoplasm, in the
ositive cases. No DNA or RNA signals were detected in
ny of the human or rodent control tissues.
These results both confirm and extend in three ways
ur previous observations of VZV latency in human gan-
lia. First, the assumption that the predominant neuronal
ocalisation of latent VZV seen in trigeminal ganglia
ould also extend to human DRG has been proved to be
orrect. The results that were obtained here show no
ifference from those obtained in trigeminal ganglia,
ither in the normal or HIV-positive cases in which alter-
FIG. 1. (A) and (B) In situ PCR for VZV DNA of serial sections of
uman dorsal root ganglion from an AIDS case for genes 4 and 40,
espectively. (C) and (D) In situ hybridisation (ISH) of serial sections
rom human dorsal root ganglion (DRG) from a normal case for VZV
ene 29 DNA and RNA, respectively. Positive signals in neuronal nuclei
an be seen in all fields. (E) and (F), Examples of negative controls. (E)
hows ISH for VZV gene 29 RNA on a 12-day-old infant trigeminal
anglion. (F) shows in situ PCR using enterovirus primers on a human
RG from an AIDS case. (x450).tions of cellular tropism might be expected because ofhe immunosuppression (Kennedy et al., 1998). Second, it
s clear that more than one region of the VZV genome is
resent in neurons during the latency process as evi-
enced by the detection of two separate regions of VZV
NA (represented by genes 4 and 40) in neurons within
he same tissue area. Our previous studies had also
dentified DNA of VZV genes 18, 21, 29, and 63 in different
rigeminal ganglia using a combination of techniques
Kennedy et al., 1998), but here we specifically identified
n five DRG multiple genes in neurons in the same tissue
rea, thereby confirming what was previously assumed.
hird, evidence was obtained to demonstrate the pres-
nce of both a particular VZV gene (gene 29) and its
ranscription in the same area of the DRG tissue.
hether this was actually the case in the same cell can
nly be established unequivocally by the development of
ouble-gene-labelling techniques in these tissue sec-
ions. Nevertheless the current data, using serial sec-
ions, lead us to believe that this is the case in VZV
atency. The results for the other VZV genes that we
ound to be transcribed in neurons in this limited RNA
creen are consistent with a number of previous studies
Croen et al., 1988; Cohrs et al., 1992, 1994–1996; Meier
t al., 1993). We are currently employing these tech-
iques to provide a detailed analysis of the transcription
f a large number of VZV genes in specific cell types in
oth normal and immunocompromised individuals.
MATERIALS AND METHODS
issues and probes
All of the experimental protocols, including extensive
egative and positive control procedures, used in the
urrent study have been previously described in detail
lsewhere (Kennedy et al., 1998) and therefore will only
e given in outline here. Formalin-fixed wax-embedded
uman lumbar DRG tissue samples from 12 individuals
ere used (kindly donated by J. Bell, Edinburgh; Table 1).
hree of these were from normal individuals and nine
TABLE 1
Human Dorsal Root Ganglia (DRG) Studied
Case Age (Yr) Sex Region Diagnosis
1 33 Male Lumbar AIDS
2 37 Male Lumbar AIDS
3 28 Male Lumbar AIDS
4 50 Male Lumbar AIDS
5 30 Male Lumbar AIDS
6 35 Male Lumbar pre-AIDS
7 27 Male Lumbar Normal (overdose)
8 26 Male Lumbar Normal (overdose)
9 26 Male Lumbar Normal (overdose)
10 46 Male Lumbar AIDS
11 26 Male Lumbar AIDS
12 29 Male Lumbar pre-AIDS
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453VZV LATENCY IN HUMAN GANGLIONIC TISSUESrom patients with acquired immunodeficiency syndrome
AIDS). Control tissues included human and rodent neu-
al and nonneural tissues as well as a trigeminal gan-
lion from a 12-day-old infant (Kennedy et al., 1998). The
ligonucleotide probes and PCR primers used in the
tudy are shown in Table 2. They included oligonucleo-
ide probes and primer sequences for VZV genes 4, 21,
9, 40, and 63, enterovirus (as a negative control) (Zoll et
l., 1992) and also human b-globin. All oligonucleotides
ere synthesized by Genosys UK.
n situ hybridisation
For most experiments, viral RNA and DNA were de-
ected using in situ hybridisation (ISH), which was car-
ied out as previously described in detail (Kennedy et al.,
998). In brief, five-mm tissue sections on APES-treated
lass slides were incubated overnight at 37°C, dewaxed
n xylene, and rehydrated through graded ethanol. After
ermeabilisation with HCl and proteinase K and then
nactivation of proteinase K by glycine/PBS followed by
cetylation, the sections were dehydrated and prehybrid-
zed in buffer containing 50% formamide, 23 SSC, Den-
ardt’s solution, and denatured salmon sperm DNA. The
ections were hybridised overnight with an appropriate
igoxigenin (DIG)-labeled probe in dextran sulfate pre-
ybridisation buffer, and standard DIG agents then used
o detect any resulting hybrids. The slides were dipped in
ppropriate buffer and blocking agent for 30 min and
reated for 60 min with antibody conjugated to alkaline
hosphatase (AP). Following equilibration in buffer,
lides were treated with the detection agent (Kennedy et
l., 1998) and 2.4 mg/ml levamisole (in the dark) for a
eriod of 15 min to 2 h until the development of the
urple colour. All slides were read blind. To colocalize
ZV DNA and RNA in the same region, serial sections
ere processed and analysed. Double-labelling the sec-
ions with two different VZV probes was not possible, and
T
Oligonucle
VZV gene
4 59-TGCAACCTCGAAGTCACTT-39*
59-CCACGGACAACTATATTAG-39
21 59-GGTCACTCCCACTTGTATTCC-3
29 59-TCATCTAGAATCTTTACTGCTTC
40 59-ATGACAACGGTTTCATGTCCCGT
59-TCTAGAAAACGCACAAAGTTTAA
63 59-CGCGCTTAAGCTACACGCCATG
Enterovirus Z1 59-CAAGCACTTCTGTTTCCCCGG
Z3 59-ATTGTCACCATAAGCAGCCA-
b-Globin (180 bp) 59-CTGTGGGGCAAGGTGAACG-39
59-CAAAGGACTCAAAGAACCTC-39
Note. All VZV sequences obtained from Davison and Scott (1986). *,ot all of the probes were used in all cases.CR in situ amplification
PCR in situ amplification to detect viral DNA was
arried out as previously described in detail (Kennedy
t al., 1998). In brief, 5-mm wax sections on APES-
oated glass slides were incubated at 60°C for 24–48
and then dewaxed in xylene and rehydrated in
raded ethanol prior to treatment with 0.02 M HCl.
fter treatment with Triton-X and then proteinase K,
he tissue samples were boiled in citric acid for 3 min,
ixed in 20% acetic acid, washed in PBS, and then
ehydrated through graded ethanols. For PCR in situ,
e used the Perkin–Elmer Gene Amp system 1000.
he composition of the PCR mastermixes was as pre-
iously described (Kennedy et al., 1998). Slides were
ir-dried and 50 ml of the PCR mix placed onto
ach section prior to amplification. The cycling param-
ters for VZV amplifications were as previously de-
ailed (Kennedy et al., 1998), following which the slides
ere cooled to 4°C, washed in 23 SSC, and pro-
essed for colour development as above. The maxi-
um duration of slide immersion in the detection re-
gent was 30 min.
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